|
Biological Activity:
Selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
References: online 1
G Blackledge, S Averbuch. Gefitinib ('Iressa', ZD1839) and new epidermal growth factor receptor inhibitors. Br. J. Cancer 2004, 90(3), 566-72 (review).
JG Paez et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304(5676), 1497-500.
Chemical Name: N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
|